BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 502784)

  • 1. [Late sequelae of the inhalational uptake of 239Pu under the influence of Ca- or ZnDTPA therapy].
    Levdik TI; Liubchanskii ER; Nifatov AP
    Med Radiol (Mosk); 1979 Nov; 24(11):66-71. PubMed ID: 502784
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Zn-DTPA and Ca-DTPA in removing plutonium from the human body.
    Ohlenschläger L; Schieferdecker H; Schmidt-Martin W
    Health Phys; 1978 Nov; 35(5):694-9. PubMed ID: 744734
    [No Abstract]   [Full Text] [Related]  

  • 3. Removal of internally deposited transuranium elements by Zn-DTPA.
    Seidel A; Volf V
    Health Phys; 1972 Jun; 22(6):779-83. PubMed ID: 5084010
    [No Abstract]   [Full Text] [Related]  

  • 4. Plutonium: biomedical research.
    Bair WJ; Thompson RC
    Science; 1974 Feb; 183(4126):715-22. PubMed ID: 4595239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological action of 239Pu during intake by inhalation and complexon therapy with Zn or Ca DTPA under experimental conditions].
    Siniakov EG; Nifatov AP; Liubchanskiĭ ER; Bazhin AG
    Med Radiol (Mosk); 1988 May; 33(5):58-61. PubMed ID: 3374306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior and biological action of large amounts of 239Pu following intramuscular administration in rats undergoing long-term therapy with Zn- and Ca-DTPA].
    Siniakov EG; Bazhin AG; Liubchanskiĭ ER; Nifatov AP
    Radiobiologiia; 1987; 27(1):129-30. PubMed ID: 3469686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decorporation from beagles of a mixture of monomeric and particulate plutonium using Ca-DTPA and Zn-DTPA: dependence upon frequency of administration.
    Lloyd RD; Boseman JJ; Taylor GN; Bruenger FW; Atherton DR; Stevens W; Mays CW
    Health Phys; 1978 Aug; 35(2):217-27. PubMed ID: 701018
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of DTPA therapy on long-term effects of retained monomeric plutonium: comparison with polymeric plutonium.
    Osenthal MW; Lindenbaum A
    Radiat Res; 1967 Jul; 31(3):506-21. PubMed ID: 6027890
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of standard Licam (C) in plutonium radiocontamination].
    Gerasimo P; Duserre C; Ducousso R; Metivier H
    Ann Pharm Fr; 1987; 45(3):189-94. PubMed ID: 3434970
    [No Abstract]   [Full Text] [Related]  

  • 10. Removal of plutonium from beagles using Ca-DTPA and Zn-DTPA: effects on initial DTPA injection.
    Taylor GN; Lloyd RD; Boseman JJ; Atherton DR; Mays CW
    Health Phys; 1978 Aug; 35(2):201-10. PubMed ID: 701016
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ascorbate ions in DTPA treatment after contamination by mixed plutonium dioxide-sodium burning products.
    Métvier H; Masse R; Nolibé D; Nénot JC; Lafuma J
    Health Phys; 1977 May; 32(5):450-2. PubMed ID: 881345
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined effect of DTPA and citrate on an intramuscular 239Pu deposit in rats.
    Volf V
    Health Phys; 1974 Jul; 27(1):152-3. PubMed ID: 4430623
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress in the beagle studies at Colorado State University.
    Watters RL; Lebel JL
    Health Phys; 1972 Jun; 22(6):811-4. PubMed ID: 5084015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior and biological effect of 239Pu on entry into a skin abrasion].
    Bazhin AG; Liubchanskiĭ ER; Nifatov AN; Siniakov EG
    Med Radiol (Mosk); 1983 Feb; 28(2):46-51. PubMed ID: 6835046
    [No Abstract]   [Full Text] [Related]  

  • 15. Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I.
    Guilmette RA; Moretti ES; Lindenbaum A
    Radiat Res; 1979 Jun; 78(3):415-28. PubMed ID: 221958
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of phagocytosis and the effect of different DTPA salts on the mechanism of lung self-purification of 239Pu].
    Levdik TI; Osobets SV
    Med Radiol (Mosk); 1980 Oct; 25(10):44-8. PubMed ID: 7421452
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhalation carcinogenesis of high-fired 239PuO2 in rats.
    Sanders CL; Dagle GE; Cannon WC; Craig DK; Powers GJ; Meier DM
    Radiat Res; 1976 Nov; 68(2):349-60. PubMed ID: 988604
    [No Abstract]   [Full Text] [Related]  

  • 18. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of inhaled 239PuF4 in beagles. BNWL-714.
    Dilley JV; McDonald KE
    BNWL Rep; 1968 May; ():6.11. PubMed ID: 5306301
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of oral ZnDTPA on late effects of injected plutonium in rat.
    Volf V; Luz A; Schäffer E; Müller WA; Rencová J
    Int J Radiat Biol; 1999 Aug; 75(8):929-41. PubMed ID: 10465359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.